Abstract

Unlike the CSF biomarkers evaluated, changes in serial structural MRI are correlated with concurrent change on general cognitive and functional indices in impaired subjects, track with clinical disease stage, and are influenced by APOE genotype.

Keywords

BiomarkerMedicineNeuroimagingInternal medicineClinical trialImaging biomarkerAlzheimer's diseaseCerebrospinal fluidBrain sizeCorrelationCardiologyMagnetic resonance imagingPsychologyOncologyPathologyDiseaseRadiologyPsychiatry

Affiliated Institutions

Related Publications

The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of developing criteria for the symptomatic predementia phase of Alzheimer's dis...

2011 Alzheimer s & Dementia 9670 citations

Publication Info

Year
2010
Type
article
Volume
75
Issue
2
Pages
143-151
Citations
161
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

161
OpenAlex

Cite This

Prashanthi Vemuri, H. Wiste, Stephen D. Weigand et al. (2010). Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology , 75 (2) , 143-151. https://doi.org/10.1212/wnl.0b013e3181e7ca82

Identifiers

DOI
10.1212/wnl.0b013e3181e7ca82